Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Daily versus intermittent ferrous sulphate in pregnant women with moderate iron deficiency anaemia
PACTR202506632677229Phase 1Not yet recruiting
- Sponsor
- Okwara Ifeanyi Dickson
- Start
- Jun 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, open-label trial of ferrous sulfate in iron deficiency anemia (IDA), sponsored by Okwara Ifeanyi Dickson. Planned start Jun 2025; status: not yet recruiting.
02
Drugs
ferrous sulfate
03
Conditions
iron deficiency anemia (IDA)
Beyond the preview
Go deeper on PACTR202506632677229.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on PACTR202506632677229.